Acarbose
Generic name: Pronounced as (ay' car bose)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 12/15/2017
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
Why is this medication prescribed?
Acarbose is used (with diet only or diet and other medications) to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) . Acarbose works by slowing the action of certain chemicals that break down food to release glucose (sugar) into your blood. Slowing food digestion helps keep blood glucose from rising very high after meals.
Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
How should this medicine be used?
Acarbose comes as a tablet to take by mouth. It is usually taken three times a day. It is very important to take each dose with the first bite of each main meal. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take acarbose exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Continue to take acarbose even if you feel well. Do not stop taking acarbose without talking to your doctor.
Other uses for this medicine
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking acarbose,
-
tell your doctor and pharmacist if you are allergic to acarbose or any other drugs.
-
tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially other medications for diabetes, digoxin (Lanoxin), diuretics ('water pills'), estrogens, isoniazid, medications for high blood pressure or colds, oral contraceptives, pancreatic enzymes, phenytoin (Dilantin), steroids, thyroid medications, and vitamins.
-
tell your doctor if you have or have ever had ketoacidosis, cirrhosis, or intestinal disease such as inflammatory bowel disease or bowel obstruction.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking acarbose, call your doctor.
-
if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking acarbose.
What special dietary instructions should I follow?
Be sure to follow all exercise and dietary recommendations made by your doctor or dietitian. It is important to eat a healthful diet.
Alcohol may cause a decrease in blood sugar. Ask your doctor about the safe use of alcoholic beverages while you are taking acarbose.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. If you will be having a snack soon, take a dose with the snack. If it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
When used in combination with insulin or other medications used to treat diabetes, acarbose may cause excessive lowering of blood sugar levels.
-
If you have any of these symptoms, glucose products (Insta-Glucose or B-D Glucose tablets) should be used and you should call your doctor. Because acarbose blocks the breakdown of table sugar and other complex sugars, fruit juice or other products containing these sugars will not help to increase blood sugar. It is important that you and other members of your household understand this difference between acarbose and other medications used to treat diabetes.
-
shakiness
-
dizziness or lightheadedness
-
sweating
-
nervousness or irritability
-
sudden changes in behavior or mood
-
headache
-
numbness or tingling around the mouth
-
weakness
-
pale skin
-
hunger
-
clumsy or jerky movements
-
-
If hypoglycemia is not treated, severe symptoms may develop. Be sure that your family, friends, and other people who spend time with you know that if you have any of the following symptoms, they should get medical treatment for you immediately.
-
confusion
-
seizures
-
loss of consciousness
-
-
Call your doctor immediately if you have any of the following symptoms of hyperglycemia (high blood sugar):
-
extreme thirst
-
frequent urination
-
extreme hunger
-
weakness
-
blurred vision
-
-
If high blood sugar is not treated, a serious, life-threatening condition called diabetic ketoacidosis could develop. Call your doctor immediately if you have any of the these symptoms:
-
dry mouth
-
upset stomach and vomiting
-
shortness of breath
-
breath that smells fruity
-
decreased consciousness
-
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your response to acarbose. Your doctor will also tell you how to check your response to this medication by measuring your blood or urine sugar levels at home. Follow these instructions carefully
You should always wear a diabetic identification bracelet to be sure you get proper treatment in an emergency.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Moxifloxacin | Moxifloxacin The therapeutic efficacy of Acarbose can be increased when used in combination with Moxifloxacin. |
Repaglinide | Repaglinide The risk or severity of hypoglycemia can be increased when Acarbose is combined with Repaglinide. |
Insulin Glargine (rDNA origin) Injection | Insulin Glargine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Acarbose. |
Cilostazol | Cilostazol Acarbose may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Acarbose may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level. |
Fenofibrate | Fenofibrate Acarbose may decrease the excretion rate of Fenofibrate which could result in a higher serum level. |
Guanfacine | Guanfacine Acarbose may decrease the excretion rate of Guanfacine which could result in a higher serum level. |
Magnesium Hydroxide | Magnesium Hydroxide Acarbose may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level. |
Miglitol | Miglitol The risk or severity of hypoglycemia can be increased when Acarbose is combined with Miglitol. |
Mycophenolate | Mycophenolate Acarbose may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level. |
Olsalazine | Olsalazine Olsalazine may increase the hypoglycemic activities of Acarbose. |
Penbutolol | Penbutolol The therapeutic efficacy of Acarbose can be increased when used in combination with Acebutolol. |
Potassium | Potassium Potassium may increase the excretion rate of Acarbose which could result in a lower serum level and potentially a reduction in efficacy. |
Prednisone | Prednisone The risk or severity of hyperglycemia can be increased when Prednisone is combined with Acarbose. |
Ranitidine | Ranitidine Acarbose may decrease the excretion rate of Ranitidine which could result in a higher serum level. |
Reserpine | Reserpine Reserpine may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Rizatriptan | Rizatriptan Acarbose may decrease the excretion rate of Rizatriptan which could result in a higher serum level. |
Sumatriptan | Sumatriptan The therapeutic efficacy of Acarbose can be increased when used in combination with Sumatriptan. |
Tacrolimus | Tacrolimus The therapeutic efficacy of Acarbose can be decreased when used in combination with Tacrolimus. |
Triamcinolone | Triamcinolone The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Acarbose. |
Ampicillin Injection | Ampicillin Injection Acarbose may decrease the excretion rate of Ampicillin which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection Doxycycline may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Fluconazole Injection | Fluconazole Injection The risk or severity of hypoglycemia can be increased when Acarbose is combined with Fluconazole. |
Foscarnet Injection | Foscarnet Injection Foscarnet may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Hydromorphone Injection | Hydromorphone Injection Acarbose may decrease the excretion rate of Hydromorphone which could result in a higher serum level. |
Levofloxacin Injection | Levofloxacin Injection The therapeutic efficacy of Acarbose can be increased when used in combination with Levofloxacin. |
Meperidine Injection | Meperidine Injection Acarbose may decrease the excretion rate of Meperidine which could result in a higher serum level. |
Methylprednisolone Injection | Methylprednisolone Injection The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Acarbose. |
Metoclopramide Injection | Metoclopramide Injection Acarbose may decrease the excretion rate of Metoclopramide which could result in a higher serum level. |
Pamidronate Injection | Pamidronate Injection Pamidronic acid may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Vancomycin Injection | Vancomycin Injection Acarbose may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Altretamine | Altretamine Amphetamine may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Cefuroxime | Cefuroxime Cefuroxime may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Cyclosporine | Cyclosporine Cyclosporine may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Torsemide | Torsemide The therapeutic efficacy of Acarbose can be increased when used in combination with Torasemide. |
Olanzapine | Olanzapine The therapeutic efficacy of Acarbose can be decreased when used in combination with Olanzapine. |
Hydroxychloroquine | Hydroxychloroquine The therapeutic efficacy of Acarbose can be increased when used in combination with Hydroxychloroquine. |
Meloxicam | Meloxicam Meloxicam may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Pantoprazole | Pantoprazole Pantoprazole may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Temozolomide | Temozolomide Acarbose may decrease the excretion rate of Temozolomide which could result in a higher serum level. |
Zaleplon | Zaleplon Acarbose may decrease the excretion rate of Zaleplon which could result in a higher serum level. |
Linezolid | Linezolid Linezolid may increase the hypoglycemic activities of Acarbose. |
Trimipramine | Trimipramine Trimipramine may decrease the hypoglycemic activities of Acarbose. |
Perindopril | Perindopril Acarbose may decrease the excretion rate of Perindopril which could result in a higher serum level. |
Tenofovir | Tenofovir Tenofovir may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Sirolimus | Sirolimus The therapeutic efficacy of Acarbose can be decreased when used in combination with Sirolimus. |
Epinephrine Injection | Epinephrine Injection The therapeutic efficacy of Acarbose can be decreased when used in combination with Epinephrine. |
Eplerenone | Eplerenone Eplerenone may increase the excretion rate of Acarbose which could result in a lower serum level and potentially a reduction in efficacy. |
Escitalopram | Escitalopram The risk or severity of hypoglycemia can be increased when Acarbose is combined with Escitalopram. |
Zonisamide | Zonisamide The therapeutic efficacy of Acarbose can be increased when used in combination with Zonisamide. |
Aripiprazole | Aripiprazole The therapeutic efficacy of Acarbose can be decreased when used in combination with Aripiprazole. |
Atomoxetine | Atomoxetine Acarbose may decrease the excretion rate of Atomoxetine which could result in a higher serum level. |
Atazanavir | Atazanavir The therapeutic efficacy of Acarbose can be decreased when used in combination with Atazanavir. |
Almotriptan | Almotriptan Acarbose may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Rosuvastatin | Rosuvastatin The therapeutic efficacy of Acarbose can be increased when used in combination with Rosuvastatin. |
Emtricitabine | Emtricitabine Acarbose may decrease the excretion rate of Emtricitabine which could result in a higher serum level. |
Memantine | Memantine Acarbose may decrease the excretion rate of Memantine which could result in a higher serum level. |
Tadalafil | Tadalafil Acarbose may decrease the excretion rate of Tadalafil which could result in a higher serum level. |
Fosamprenavir | Fosamprenavir The therapeutic efficacy of Acarbose can be decreased when used in combination with Fosamprenavir. |
Gemifloxacin | Gemifloxacin The therapeutic efficacy of Acarbose can be increased when used in combination with Gemifloxacin. |
Progesterone | Progesterone The therapeutic efficacy of Acarbose can be decreased when used in combination with Progesterone. |
Oxandrolone | Oxandrolone Oxandrolone may increase the hypoglycemic activities of Acarbose. |
Protriptyline | Protriptyline Protriptyline may decrease the hypoglycemic activities of Acarbose. |
Duloxetine | Duloxetine The risk or severity of hypoglycemia can be increased when Acarbose is combined with Duloxetine. |
Norethindrone | Norethindrone The therapeutic efficacy of Acarbose can be decreased when used in combination with Norethisterone. |
Tinidazole | Tinidazole Acarbose may decrease the excretion rate of Tinidazole which could result in a higher serum level. |
Bosentan | Bosentan The therapeutic efficacy of Acarbose can be increased when used in combination with Bosentan. |
Cefditoren | Cefditoren Acarbose may decrease the excretion rate of Cefdinir which could result in a higher serum level. |
Cyanocobalamin Injection | Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Eszopiclone | Eszopiclone Acarbose may decrease the excretion rate of Eszopiclone which could result in a higher serum level. |
Ganciclovir | Ganciclovir Acarbose may decrease the excretion rate of Ganciclovir which could result in a higher serum level. |
Insulin Aspart (rDNA Origin) Injection | Insulin Aspart (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Acarbose is combined with Insulin aspart. |
Ribavirin | Ribavirin Acarbose may decrease the excretion rate of Ribavirin which could result in a higher serum level. |
Valganciclovir | Valganciclovir Acarbose may decrease the excretion rate of Valganciclovir which could result in a higher serum level. |
Adefovir | Adefovir Adefovir may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Dextroamphetamine | Dextroamphetamine Amphetamine may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Pramlintide Injection | Pramlintide Injection The risk or severity of hypoglycemia can be increased when Acarbose is combined with Pramlintide. |
Exenatide Injection | Exenatide Injection The risk or severity of hypoglycemia can be increased when Acarbose is combined with Exenatide. |
Isocarboxazid | Isocarboxazid Isocarboxazid may increase the hypoglycemic activities of Acarbose. |
Ramelteon | Ramelteon Acarbose may decrease the excretion rate of Ramelteon which could result in a higher serum level. |
Fentanyl | Fentanyl Acarbose may decrease the excretion rate of Fentanyl which could result in a higher serum level. |
Pregabalin | Pregabalin The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Acarbose. |
Tipranavir | Tipranavir The therapeutic efficacy of Acarbose can be decreased when used in combination with Tipranavir. |
Insulin Detemir (rDNA Origin) Injection | Insulin Detemir (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Acarbose is combined with Insulin detemir. |
Ranolazine | Ranolazine Ranolazine may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Rasagiline | Rasagiline Acarbose may decrease the excretion rate of Rasagiline which could result in a higher serum level. |
Sitagliptin | Sitagliptin The risk or severity of hypoglycemia can be increased when Acarbose is combined with Sitagliptin. |
Varenicline | Varenicline Acarbose may decrease the excretion rate of Varenicline which could result in a higher serum level. |
Albuterol | Albuterol Acarbose may decrease the excretion rate of Salbutamol which could result in a higher serum level. |
Paliperidone | Paliperidone The therapeutic efficacy of Acarbose can be decreased when used in combination with Paliperidone. |
Clofarabine Injection | Clofarabine Injection Acarbose may decrease the excretion rate of Clofarabine which could result in a higher serum level. |
Insulin Glulisine (rDNA origin) Injection | Insulin Glulisine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Acarbose is combined with Insulin glulisine. |
Lubiprostone | Lubiprostone Acarbose may decrease the excretion rate of Lubiprostone which could result in a higher serum level. |
Bismuth Subsalicylate | Bismuth Subsalicylate Bismuth subsalicylate may increase the hypoglycemic activities of Acarbose. |
Darunavir | Darunavir The therapeutic efficacy of Acarbose can be increased when used in combination with Darunavir. |
Pemetrexed Injection | Pemetrexed Injection Acarbose may decrease the excretion rate of Pemetrexed which could result in a higher serum level. |
Vorinostat | Vorinostat The therapeutic efficacy of Acarbose can be decreased when used in combination with Vorinostat. |
Sorafenib | Sorafenib Acarbose may decrease the excretion rate of Sorafenib which could result in a higher serum level. |
Sunitinib | Sunitinib The risk or severity of hypoglycemia can be increased when Acarbose is combined with Sunitinib. |
Levocetirizine | Levocetirizine Acarbose may decrease the excretion rate of Levocetirizine which could result in a higher serum level. |
Pegaptanib Injection | Pegaptanib Injection Acarbose may decrease the excretion rate of Pegaptanib which could result in a higher serum level. |
Azacitidine Injection | Azacitidine Injection Acarbose may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Temsirolimus | Temsirolimus The therapeutic efficacy of Acarbose can be decreased when used in combination with Temsirolimus. |
Lenalidomide | Lenalidomide Acarbose may decrease the excretion rate of Lenalidomide which could result in a higher serum level. |
Nilotinib | Nilotinib The therapeutic efficacy of Acarbose can be decreased when used in combination with Nilotinib. |
Budesonide | Budesonide The risk or severity of hyperglycemia can be increased when Acarbose is combined with Budesonide. |
Desmopressin | Desmopressin Desmopressin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Doripenem Injection | Doripenem Injection Acarbose may decrease the excretion rate of Doripenem which could result in a higher serum level. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The therapeutic efficacy of Acarbose can be decreased when used in combination with Arsenic trioxide. |
Desvenlafaxine | Desvenlafaxine The risk or severity of hypoglycemia can be increased when Acarbose is combined with Desvenlafaxine. |
Cevimeline | Cevimeline Cevimeline may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Nebivolol | Nebivolol The therapeutic efficacy of Acarbose can be increased when used in combination with Nebivolol. |
Certolizumab Injection | Certolizumab Injection Acarbose may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level. |
Daptomycin Injection | Daptomycin Injection Daptomycin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Methylnaltrexone Injection | Methylnaltrexone Injection Acarbose may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. |
Midazolam | Midazolam Acarbose may decrease the excretion rate of Midazolam which could result in a higher serum level. |
Dexrazoxane Injection | Dexrazoxane Injection Acarbose may decrease the excretion rate of Dexrazoxane which could result in a higher serum level. |
Milnacipran | Milnacipran The risk or severity of hypoglycemia can be increased when Acarbose is combined with Milnacipran. |
Plerixafor Injection | Plerixafor Injection Acarbose may decrease the excretion rate of Plerixafor which could result in a higher serum level. |
Fesoterodine | Fesoterodine Acarbose may decrease the excretion rate of Fesoterodine which could result in a higher serum level. |
Betaxolol | Betaxolol The therapeutic efficacy of Acarbose can be increased when used in combination with Betaxolol. |
Iloperidone | Iloperidone The therapeutic efficacy of Acarbose can be decreased when used in combination with Iloperidone. |
Prasugrel | Prasugrel Acarbose may decrease the excretion rate of Prasugrel which could result in a higher serum level. |
Everolimus | Everolimus The therapeutic efficacy of Acarbose can be decreased when used in combination with Everolimus. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Acarbose which could result in a lower serum level and potentially a reduction in efficacy. |
Pralatrexate Injection | Pralatrexate Injection Acarbose may decrease the excretion rate of Pralatrexate which could result in a higher serum level. |
Palonosetron Injection | Palonosetron Injection Acarbose may decrease the excretion rate of Palonosetron which could result in a higher serum level. |
Saxagliptin | Saxagliptin The risk or severity of hypoglycemia can be increased when Acarbose is combined with Saxagliptin. |
Telavancin Injection | Telavancin Injection Acarbose may decrease the excretion rate of Telavancin which could result in a higher serum level. |
Topotecan | Topotecan Acarbose may decrease the excretion rate of Topotecan which could result in a higher serum level. |
Asenapine | Asenapine The therapeutic efficacy of Acarbose can be decreased when used in combination with Asenapine. |
Levonorgestrel | Levonorgestrel The therapeutic efficacy of Acarbose can be decreased when used in combination with Levonorgestrel. |
Liraglutide Injection | Liraglutide Injection The risk or severity of hypoglycemia can be increased when Acarbose is combined with Liraglutide. |
Dalfampridine | Dalfampridine Acarbose may decrease the excretion rate of Dalfampridine which could result in a higher serum level. |
Ceftaroline Injection | Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Lurasidone | Lurasidone The therapeutic efficacy of Acarbose can be decreased when used in combination with Lurasidone. |
Acetaminophen Injection | Acetaminophen Injection Acarbose may decrease the excretion rate of Acetaminophen which could result in a higher serum level. |
Ipilimumab Injection | Ipilimumab Injection Acarbose may decrease the excretion rate of Ipilimumab which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Terbutaline Injection | Terbutaline Injection Acarbose may decrease the excretion rate of Terbutaline which could result in a higher serum level. |
Roflumilast | Roflumilast Acarbose may decrease the excretion rate of Roflumilast which could result in a higher serum level. |
Linagliptin | Linagliptin The risk or severity of hypoglycemia can be increased when Acarbose is combined with Linagliptin. |
Triptorelin Injection | Triptorelin Injection The therapeutic efficacy of Acarbose can be decreased when used in combination with Triptorelin. |
Rivaroxaban | Rivaroxaban Acarbose may decrease the excretion rate of Rivaroxaban which could result in a higher serum level. |
Ruxolitinib | Ruxolitinib Acarbose may decrease the excretion rate of Ruxolitinib which could result in a higher serum level. |
Clobazam | Clobazam Acarbose may decrease the excretion rate of Clobazam which could result in a higher serum level. |
Vemurafenib | Vemurafenib The therapeutic efficacy of Acarbose can be increased when used in combination with Vemurafenib. |
Deferiprone | Deferiprone Acarbose may decrease the excretion rate of Deferiprone which could result in a higher serum level. |
Naloxone Injection | Naloxone Injection Acarbose may decrease the excretion rate of Naloxone which could result in a higher serum level. |
Fondaparinux Injection | Fondaparinux Injection Acarbose may decrease the excretion rate of Fondaparinux which could result in a higher serum level. |
Enzalutamide | Enzalutamide Acarbose may decrease the excretion rate of Enzalutamide which could result in a higher serum level. |
Mirabegron | Mirabegron Acarbose may decrease the excretion rate of Mirabegron which could result in a higher serum level. |
Corticotropin, Repository Injection | Corticotropin, Repository Injection The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Acarbose. |
Lorcaserin | Lorcaserin The risk or severity of hypoglycemia can be increased when Acarbose is combined with Mecasermin. |
Teduglutide Injection | Teduglutide Injection Acarbose may decrease the excretion rate of Teduglutide which could result in a higher serum level. |
Alogliptin | Alogliptin The risk or severity of hypoglycemia can be increased when Acarbose is combined with Alogliptin. |
Pomalidomide | Pomalidomide Acarbose may decrease the excretion rate of Pomalidomide which could result in a higher serum level. |
Canagliflozin | Canagliflozin Canagliflozin may increase the hypoglycemic activities of Acarbose. |
Methazolamide | Methazolamide Methazolamide may increase the excretion rate of Acarbose which could result in a lower serum level and potentially a reduction in efficacy. |
Dabrafenib | Dabrafenib The therapeutic efficacy of Acarbose can be decreased when used in combination with Dabrafenib. |
Trametinib | Trametinib Acarbose may decrease the excretion rate of Trametinib which could result in a higher serum level. |
Levomilnacipran | Levomilnacipran The risk or severity of hypoglycemia can be increased when Acarbose is combined with Levomilnacipran. |
Ertapenem Injection | Ertapenem Injection Acarbose may decrease the excretion rate of Ertapenem which could result in a higher serum level. |
Vortioxetine | Vortioxetine Acarbose may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ketorolac Injection | Ketorolac Injection Ketorolac may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Simeprevir | Simeprevir The therapeutic efficacy of Acarbose can be increased when used in combination with Simeprevir. |
Sofosbuvir | Sofosbuvir Acarbose may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin Dapagliflozin may increase the hypoglycemic activities of Acarbose. |
Apremilast | Apremilast Acarbose may decrease the excretion rate of Apremilast which could result in a higher serum level. |
Droxidopa | Droxidopa Acarbose may decrease the excretion rate of Droxidopa which could result in a higher serum level. |
Ceritinib | Ceritinib The therapeutic efficacy of Acarbose can be decreased when used in combination with Ceritinib. |
Albiglutide Injection | Albiglutide Injection The risk or severity of hypoglycemia can be increased when Acarbose is combined with Albiglutide. |
Testosterone Injection | Testosterone Injection Acarbose may decrease the excretion rate of Testosterone which could result in a higher serum level. |
Empagliflozin | Empagliflozin The risk or severity of hypoglycemia can be increased when Acarbose is combined with Empagliflozin. |
Dulaglutide Injection | Dulaglutide Injection The risk or severity of hypoglycemia can be increased when Acarbose is combined with Dulaglutide. |
Edoxaban | Edoxaban Acarbose may decrease the excretion rate of Edoxaban which could result in a higher serum level. |
Methamphetamine | Methamphetamine Acarbose may decrease the excretion rate of Metamfetamine which could result in a higher serum level. |
Tasimelteon | Tasimelteon Acarbose may decrease the excretion rate of Tasimelteon which could result in a higher serum level. |
Lanreotide Injection | Lanreotide Injection The therapeutic efficacy of Acarbose can be decreased when used in combination with Lanreotide. |
Risperidone Injection | Risperidone Injection The therapeutic efficacy of Acarbose can be decreased when used in combination with Risperidone. |
Insulin Human Inhalation | Insulin Human Inhalation The risk or severity of hypoglycemia can be increased when Insulin human is combined with Acarbose. |
Haloperidol Injection | Haloperidol Injection The therapeutic efficacy of Acarbose can be decreased when used in combination with Haloperidol. |
Amiloride | Amiloride Amiloride may increase the excretion rate of Acarbose which could result in a lower serum level and potentially a reduction in efficacy. |
Macitentan | Macitentan Acarbose may decrease the excretion rate of Macitentan which could result in a higher serum level. |
Prednisolone | Prednisolone The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Acarbose. |
Brexpiprazole | Brexpiprazole The therapeutic efficacy of Acarbose can be decreased when used in combination with Brexpiprazole. |
Ziprasidone Injection | Ziprasidone Injection The therapeutic efficacy of Acarbose can be decreased when used in combination with Ziprasidone. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Acarbose may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Insulin Degludec (rDNA Origin) Injection | Insulin Degludec (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Acarbose is combined with Insulin degludec. |
Ixazomib | Ixazomib Acarbose may decrease the excretion rate of Ixazomib which could result in a higher serum level. |
Lesinurad | Lesinurad Acarbose may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Dexamethasone Injection | Dexamethasone Injection The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Acarbose. |
Brivaracetam Injection | Brivaracetam Injection Acarbose may decrease the excretion rate of Brivaracetam which could result in a higher serum level. |
Furosemide Injection | Furosemide Injection The therapeutic efficacy of Acarbose can be increased when used in combination with Furosemide. |
Lixisenatide Injection | Lixisenatide Injection The risk or severity of hypoglycemia can be increased when Acarbose is combined with Lixisenatide. |
Doxepin (Insomnia) | Doxepin (Insomnia) Doxepin may decrease the hypoglycemic activities of Acarbose. |
Deutetrabenazine | Deutetrabenazine Acarbose may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level. |
Valbenazine | Valbenazine Acarbose may decrease the excretion rate of Valbenazine which could result in a higher serum level. |
Deflazacort | Deflazacort The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Acarbose. |
Safinamide | Safinamide Safinamide may increase the hypoglycemic activities of Acarbose. |
Naldemedine | Naldemedine Acarbose may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Benznidazole | Benznidazole Acarbose may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Delafloxacin | Delafloxacin The therapeutic efficacy of Acarbose can be increased when used in combination with Delafloxacin. |
Semaglutide Injection | Semaglutide Injection The risk or severity of hypoglycemia can be increased when Acarbose is combined with Semaglutide. |
Ertugliflozin | Ertugliflozin The therapeutic efficacy of Acarbose can be increased when used in combination with Ertugliflozin. |
Apalutamide | Apalutamide Acarbose may decrease the excretion rate of Apalutamide which could result in a higher serum level. |
Baricitinib | Baricitinib Acarbose may decrease the excretion rate of Baricitinib which could result in a higher serum level. |
Lofexidine | Lofexidine Acarbose may decrease the excretion rate of Lofexidine which could result in a higher serum level. |
Plazomicin Injection | Plazomicin Injection Acarbose may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Stiripentol | Stiripentol Acarbose may decrease the excretion rate of Stiripentol which could result in a higher serum level. |
Prucalopride | Prucalopride Acarbose may decrease the excretion rate of Prucalopride which could result in a higher serum level. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Solriamfetol | Solriamfetol Acarbose may decrease the excretion rate of Solriamfetol which could result in a higher serum level. |
Pitolisant | Pitolisant Acarbose may decrease the excretion rate of Pitolisant which could result in a higher serum level. |
Teprotumumab-trbw Injection | Teprotumumab-trbw Injection The therapeutic efficacy of Acarbose can be decreased when used in combination with Teprotumumab. |
Octreotide | Octreotide The therapeutic efficacy of Acarbose can be decreased when used in combination with Octreotide. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives The therapeutic efficacy of Acarbose can be decreased when used in combination with Drospirenone. |
Viloxazine | Viloxazine Acarbose may decrease the excretion rate of Viloxazine which could result in a higher serum level. |
Tobramycin Injection | Tobramycin Injection Tobramycin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Fenoprofen | Fenoprofen Fenoprofen may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Indomethacin | Indomethacin Indomethacin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Mefenamic Acid | Mefenamic Acid Mefenamic acid may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Naproxen | Naproxen Naproxen may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Tolmetin | Tolmetin Tolmetin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Sulindac | Sulindac Sulindac may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Isotretinoin | Isotretinoin Acarbose may decrease the excretion rate of Isotretinoin which could result in a higher serum level. |
Sucralfate | Sucralfate Acarbose may decrease the excretion rate of Sucralfate which could result in a higher serum level. |
Floxuridine | Floxuridine Acarbose may decrease the excretion rate of Floxuridine which could result in a higher serum level. |
Metaxalone | Metaxalone Acarbose may decrease the excretion rate of Metaxalone which could result in a higher serum level. |
Methotrexate Injection | Methotrexate Injection Methotrexate may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Methsuximide | Methsuximide The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Acarbose. |
Chlorpromazine | Chlorpromazine The therapeutic efficacy of Acarbose can be decreased when used in combination with Chlorpromazine. |
Diazepam | Diazepam Acarbose may decrease the excretion rate of Diazepam which could result in a higher serum level. |
Oxazepam | Oxazepam Acarbose may decrease the excretion rate of Oxazepam which could result in a higher serum level. |
Flurazepam | Flurazepam Acarbose may decrease the excretion rate of Flurazepam which could result in a higher serum level. |
Clorazepate | Clorazepate Acarbose may decrease the excretion rate of Clorazepic acid which could result in a higher serum level. |
Lorazepam | Lorazepam Lorazepam may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Carmustine | Carmustine Carmustine may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Amantadine | Amantadine Acarbose may decrease the excretion rate of Amantadine which could result in a higher serum level. |
Codeine | Codeine Acarbose may decrease the excretion rate of Codeine which could result in a higher serum level. |
Bromocriptine | Bromocriptine The risk or severity of hypoglycemia can be increased when Acarbose is combined with Bromocriptine. |
Tranylcypromine | Tranylcypromine Tranylcypromine may increase the hypoglycemic activities of Acarbose. |
Phenelzine | Phenelzine Acarbose may decrease the excretion rate of Phenelzine which could result in a higher serum level. |
Procarbazine | Procarbazine Procarbazine may increase the hypoglycemic activities of Acarbose. |
Tetracycline | Tetracycline Acarbose may decrease the excretion rate of Tetracycline which could result in a higher serum level. |
Bleomycin | Bleomycin Acarbose may decrease the excretion rate of Bleomycin which could result in a higher serum level. |
Sulfadiazine | Sulfadiazine The therapeutic efficacy of Acarbose can be increased when used in combination with Sulfadiazine. |
Methadone | Methadone Acarbose may decrease the excretion rate of Methadone which could result in a higher serum level. |
Benztropine | Benztropine Benzatropine may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Maprotiline | Maprotiline Acarbose may decrease the excretion rate of Maprotiline which could result in a higher serum level. |
Ibuprofen | Ibuprofen Ibuprofen may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Azathioprine | Azathioprine Acarbose may decrease the excretion rate of Azathioprine which could result in a higher serum level. |
Phentermine | Phentermine The therapeutic efficacy of Acarbose can be increased when used in combination with Phentermine. |
Methylphenidate | Methylphenidate Acarbose may decrease the excretion rate of Methylphenidate which could result in a higher serum level. |
Amoxapine | Amoxapine Amoxapine may decrease the hypoglycemic activities of Acarbose. |
Sulfasalazine | Sulfasalazine Sulfasalazine may increase the hypoglycemic activities of Acarbose. |
Hydrocortisone | Hydrocortisone The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Acarbose. |
Phenazopyridine | Phenazopyridine Phenazopyridine may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Carbamazepine | Carbamazepine Acarbose may decrease the excretion rate of Carbamazepine which could result in a higher serum level. |
Methyldopa | Methyldopa Acarbose may decrease the excretion rate of Methyldopa which could result in a higher serum level. |
Hydralazine | Hydralazine Acarbose may decrease the excretion rate of Hydralazine which could result in a higher serum level. |
Cimetidine | Cimetidine Acarbose may decrease the excretion rate of Cimetidine which could result in a higher serum level. |
Gentamicin Injection | Gentamicin Injection Gentamicin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Warfarin | Warfarin Acarbose may decrease the excretion rate of Warfarin which could result in a higher serum level. |
Clonazepam | Clonazepam Acarbose may decrease the excretion rate of Clonazepam which could result in a higher serum level. |
Loperamide | Loperamide The risk or severity of hypoglycemia can be increased when Loperamide is combined with Acarbose. |
Promethazine | Promethazine Acarbose may decrease the excretion rate of Promethazine which could result in a higher serum level. |
Meclofenamate | Meclofenamate Meclofenamic acid may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Nitrofurantoin | Nitrofurantoin Acarbose may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level. |
Digoxin | Digoxin The serum concentration of Digoxin can be decreased when it is combined with Acarbose. |
Chloroquine | Chloroquine Acarbose may decrease the excretion rate of Chloroquine which could result in a higher serum level. |
Quinine | Quinine The risk or severity of hypoglycemia can be increased when Acarbose is combined with Quinine. |
Ethosuximide | Ethosuximide The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Acarbose. |
Triamterene | Triamterene Triamterene may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Chlorothiazide | Chlorothiazide The therapeutic efficacy of Acarbose can be decreased when used in combination with Chlorothiazide. |
Chlorthalidone | Chlorthalidone The therapeutic efficacy of Acarbose can be decreased when used in combination with Chlorthalidone. |
Metolazone | Metolazone The therapeutic efficacy of Acarbose can be decreased when used in combination with Metolazone. |
Isosorbide | Isosorbide Isosorbide may increase the excretion rate of Acarbose which could result in a lower serum level and potentially a reduction in efficacy. |
Secobarbital | Secobarbital Acarbose may decrease the excretion rate of Secobarbital which could result in a higher serum level. |
Desipramine | Desipramine Desipramine may decrease the hypoglycemic activities of Acarbose. |
Amitriptyline | Amitriptyline Amitriptyline may decrease the hypoglycemic activities of Acarbose. |
Imipramine | Imipramine Imipramine may decrease the hypoglycemic activities of Acarbose. |
Probenecid | Probenecid The therapeutic efficacy of Acarbose can be increased when used in combination with Probenecid. |
Quinidine | Quinidine Acarbose may decrease the excretion rate of Quinidine which could result in a higher serum level. |
Procainamide | Procainamide Acarbose may decrease the excretion rate of Procainamide which could result in a higher serum level. |
Isoniazid | Isoniazid Acarbose may decrease the excretion rate of Isoniazid which could result in a higher serum level. |
Pyrazinamide | Pyrazinamide Acarbose may decrease the excretion rate of Pyrazinamide which could result in a higher serum level. |
Disopyramide | Disopyramide The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Acarbose. |
Butabarbital | Butabarbital Butabarbital may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Levothyroxine | Levothyroxine The therapeutic efficacy of Acarbose can be decreased when used in combination with Levothyroxine. |
Liothyronine | Liothyronine The therapeutic efficacy of Acarbose can be decreased when used in combination with Liothyronine. |
Methimazole | Methimazole Acarbose may decrease the excretion rate of Methimazole which could result in a higher serum level. |
Chlorpropamide | Chlorpropamide The risk or severity of hypoglycemia can be increased when Acarbose is combined with Chlorpropamide. |
Tolbutamide | Tolbutamide The risk or severity of hypoglycemia can be increased when Acarbose is combined with Tolbutamide. |
Tolazamide | Tolazamide The risk or severity of hypoglycemia can be increased when Acarbose is combined with Tolazamide. |
Niacin | Niacin The therapeutic efficacy of Acarbose can be decreased when used in combination with Niacin. |
Baclofen | Baclofen The therapeutic efficacy of Acarbose can be decreased when used in combination with Baclofen. |
Ethambutol | Ethambutol Acarbose may decrease the excretion rate of Ethambutol which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide The therapeutic efficacy of Acarbose can be decreased when used in combination with Methyclothiazide. |
Hydrochlorothiazide | Hydrochlorothiazide The therapeutic efficacy of Acarbose can be decreased when used in combination with Hydrochlorothiazide. |
Chlorzoxazone | Chlorzoxazone Acarbose may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level. |
Pyridoxine | Pyridoxine Pyridoxine may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Folic Acid | Folic Acid Folic acid may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Danazol | Danazol The therapeutic efficacy of Acarbose can be decreased when used in combination with Danazol. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) The therapeutic efficacy of Propranolol can be increased when used in combination with Acarbose. |
Pseudoephedrine | Pseudoephedrine The therapeutic efficacy of Acarbose can be decreased when used in combination with Pseudoephedrine. |
Nortriptyline | Nortriptyline Nortriptyline may decrease the hypoglycemic activities of Acarbose. |
Spironolactone | Spironolactone Spironolactone may increase the excretion rate of Acarbose which could result in a lower serum level and potentially a reduction in efficacy. |
Amphotericin B Injection | Amphotericin B Injection Amphotericin B may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Phytonadione | Phytonadione Acarbose may decrease the excretion rate of Phylloquinone which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Amikacin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Nadolol | Nadolol The therapeutic efficacy of Nadolol can be increased when used in combination with Acarbose. |
Allopurinol | Allopurinol Acarbose may decrease the excretion rate of Allopurinol which could result in a higher serum level. |
Fluoxymesterone | Fluoxymesterone Fluoxymesterone may increase the hypoglycemic activities of Acarbose. |
Flavoxate | Flavoxate Acarbose may decrease the excretion rate of Flavoxate which could result in a higher serum level. |
Colchicine | Colchicine Acarbose may decrease the excretion rate of Colchicine which could result in a higher serum level. |
Cefaclor | Cefaclor Cefaclor may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Cefadroxil | Cefadroxil Cefadroxil may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection Cefazolin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Cephalexin | Cephalexin Cephalexin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection Cefoxitin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Dacarbazine | Dacarbazine Acarbose may decrease the excretion rate of Dacarbazine which could result in a higher serum level. |
Acetazolamide | Acetazolamide The therapeutic efficacy of Acarbose can be increased when used in combination with Acetazolamide. |
Cefotaxime Injection | Cefotaxime Injection Cefotaxime may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Pyrantel | Pyrantel Acarbose may decrease the excretion rate of Pyrantel which could result in a higher serum level. |
Ethacrynic Acid | Ethacrynic Acid The therapeutic efficacy of Acarbose can be decreased when used in combination with Etacrynic acid. |
Colistimethate Injection | Colistimethate Injection Colistimethate may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Metoprolol | Metoprolol The therapeutic efficacy of Acarbose can be increased when used in combination with Metoprolol. |
Aspirin | Aspirin The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Acarbose. |
Salsalate | Salsalate Salsalate may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Alprazolam | Alprazolam Acarbose may decrease the excretion rate of Alprazolam which could result in a higher serum level. |
Temazepam | Temazepam Temazepam may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Triazolam | Triazolam Acarbose may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Dicyclomine | Dicyclomine Acarbose may decrease the excretion rate of Dicyclomine which could result in a higher serum level. |
Propantheline | Propantheline Acarbose may decrease the excretion rate of Propantheline which could result in a higher serum level. |
Trimethoprim | Trimethoprim Acarbose may decrease the excretion rate of Trimethoprim which could result in a higher serum level. |
Diltiazem | Diltiazem The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Acarbose. |
Nifedipine | Nifedipine Nifedipine may decrease the hypoglycemic activities of Acarbose. |
Timolol | Timolol The therapeutic efficacy of Timolol can be increased when used in combination with Acarbose. |
Verapamil | Verapamil The risk or severity of hypoglycemia can be increased when Acarbose is combined with Verapamil. |
Atenolol | Atenolol The therapeutic efficacy of Acarbose can be increased when used in combination with Atenolol. |
Pindolol | Pindolol The therapeutic efficacy of Pindolol can be increased when used in combination with Acarbose. |
Cisplatin Injection | Cisplatin Injection Acarbose may decrease the excretion rate of Cisplatin which could result in a higher serum level. |
Diflunisal | Diflunisal Diflunisal may increase the hypoglycemic activities of Acarbose. |
Piroxicam | Piroxicam Piroxicam may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Bumetanide | Bumetanide The therapeutic efficacy of Acarbose can be increased when used in combination with Bumetanide. |
Glyburide | Glyburide The risk or severity of hypoglycemia can be increased when Acarbose is combined with Glyburide. |
Glipizide | Glipizide The risk or severity of hypoglycemia can be increased when Acarbose is combined with Glipizide. |
Indapamide | Indapamide The therapeutic efficacy of Acarbose can be decreased when used in combination with Indapamide. |
Amoxicillin | Amoxicillin Acarbose may decrease the excretion rate of Amoxicillin which could result in a higher serum level. |
Oxacillin Injection | Oxacillin Injection Acarbose may decrease the excretion rate of Oxacillin which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline Acarbose may decrease the excretion rate of Pentoxifylline which could result in a higher serum level. |
Pentamidine Injection | Pentamidine Injection The therapeutic efficacy of Acarbose can be decreased when used in combination with Pentamidine. |
Ceftriaxone Injection | Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Labetalol | Labetalol The therapeutic efficacy of Labetalol can be increased when used in combination with Acarbose. |
Auranofin | Auranofin Acarbose may decrease the excretion rate of Auranofin which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection The therapeutic efficacy of Acarbose can be decreased when used in combination with Leuprolide. |
Gemfibrozil | Gemfibrozil Acarbose may decrease the excretion rate of Gemfibrozil which could result in a higher serum level. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Ceftazidime Injection | Ceftazidime Injection Ceftazidime may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Ketoprofen | Ketoprofen Ketoprofen may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Cefotetan Injection | Cefotetan Injection Cefotetan may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Flurbiprofen | Flurbiprofen Flurbiprofen may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Amiodarone | Amiodarone The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Acarbose. |
Aztreonam Injection | Aztreonam Injection Acarbose may decrease the excretion rate of Aztreonam which could result in a higher serum level. |
Buspirone | Buspirone Acarbose may decrease the excretion rate of Buspirone which could result in a higher serum level. |
Ciprofloxacin | Ciprofloxacin The therapeutic efficacy of Acarbose can be increased when used in combination with Ciprofloxacin. |
Mesalamine | Mesalamine Mesalazine may increase the hypoglycemic activities of Acarbose. |
Diclofenac | Diclofenac Diclofenac may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Fluoxetine | Fluoxetine The risk or severity of hypoglycemia can be increased when Acarbose is combined with Fluoxetine. |
Nimodipine | Nimodipine The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Acarbose. |
Clozapine | Clozapine The therapeutic efficacy of Acarbose can be decreased when used in combination with Clozapine. |
Estazolam | Estazolam Acarbose may decrease the excretion rate of Estazolam which could result in a higher serum level. |
Ofloxacin | Ofloxacin The therapeutic efficacy of Acarbose can be increased when used in combination with Ofloxacin. |
Didanosine | Didanosine Acarbose may decrease the excretion rate of Didanosine which could result in a higher serum level. |
Pentostatin Injection | Pentostatin Injection Acarbose may decrease the excretion rate of Pentostatin which could result in a higher serum level. |
Benazepril | Benazepril The risk or severity of hypoglycemia can be increased when Benazepril is combined with Acarbose. |
Etodolac | Etodolac Etodolac may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Felodipine | Felodipine The risk or severity of hypoglycemia can be increased when Felodipine is combined with Acarbose. |
Fosinopril | Fosinopril Acarbose may decrease the excretion rate of Fosinopril which could result in a higher serum level. |
Nabumetone | Nabumetone Nabumetone may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Amlodipine | Amlodipine The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Acarbose. |
Lisinopril | Lisinopril Acarbose may decrease the excretion rate of Lisinopril which could result in a higher serum level. |
Oxaprozin | Oxaprozin Oxaprozin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Sotalol | Sotalol The risk or severity of hypoglycemia can be increased when Sotalol is combined with Acarbose. |
Bisoprolol | Bisoprolol The therapeutic efficacy of Bisoprolol can be increased when used in combination with Acarbose. |
Isradipine | Isradipine The risk or severity of hypoglycemia can be increased when Isradipine is combined with Acarbose. |
Venlafaxine | Venlafaxine The risk or severity of hypoglycemia can be increased when Acarbose is combined with Venlafaxine. |
Fluvoxamine | Fluvoxamine The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Acarbose. |
Nefazodone | Nefazodone The risk or severity of hypoglycemia can be increased when Acarbose is combined with Nefazodone. |
Lamotrigine | Lamotrigine The risk or severity of hypoglycemia can be increased when Acarbose is combined with Lamotrigine. |
Valacyclovir | Valacyclovir Valaciclovir may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Tramadol | Tramadol Tramadol may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Carboplatin Injection | Carboplatin Injection Carboplatin may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Ifosfamide Injection | Ifosfamide Injection Acarbose may decrease the excretion rate of Ifosfamide which could result in a higher serum level. |
Nicardipine | Nicardipine The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Acarbose. |
Bupropion | Bupropion Acarbose may decrease the excretion rate of Bupropion which could result in a higher serum level. |
Ticlopidine | Ticlopidine Ticlopidine may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Saquinavir | Saquinavir The therapeutic efficacy of Acarbose can be decreased when used in combination with Saquinavir. |
Metformin | Metformin The risk or severity of hypoglycemia can be increased when Acarbose is combined with Metformin. |
Nisoldipine | Nisoldipine The risk or severity of hypoglycemia can be increased when Acarbose is combined with Nisoldipine. |
Lamivudine | Lamivudine Acarbose may decrease the excretion rate of Lamivudine which could result in a higher serum level. |
Glimepiride | Glimepiride The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Acarbose. |
Gemcitabine Injection | Gemcitabine Injection Acarbose may decrease the excretion rate of Gemcitabine which could result in a higher serum level. |
Indinavir | Indinavir The therapeutic efficacy of Acarbose can be decreased when used in combination with Indinavir. |
Ritonavir | Ritonavir The therapeutic efficacy of Acarbose can be decreased when used in combination with Ritonavir. |
Cidofovir Injection | Cidofovir Injection Cidofovir may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Acarbose may decrease the excretion rate of Meropenem which could result in a higher serum level. |
Clomipramine | Clomipramine Clomipramine may decrease the hypoglycemic activities of Acarbose. |
Fosfomycin | Fosfomycin Acarbose may decrease the excretion rate of Fosfomycin which could result in a higher serum level. |
Topiramate | Topiramate Topiramate may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Insulin Lispro Injection | Insulin Lispro Injection The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Acarbose. |
Pramipexole | Pramipexole Acarbose may decrease the excretion rate of Pramipexole which could result in a higher serum level. |
Nelfinavir | Nelfinavir The therapeutic efficacy of Acarbose can be decreased when used in combination with Nelfinavir. |
Carvedilol | Carvedilol The therapeutic efficacy of Acarbose can be increased when used in combination with Carvedilol. |
Nilutamide | Nilutamide Acarbose may decrease the excretion rate of Nilutamide which could result in a higher serum level. |
Flutamide | Flutamide Acarbose may decrease the excretion rate of Flutamide which could result in a higher serum level. |
Selegiline | Selegiline Selegiline may increase the hypoglycemic activities of Acarbose. |
Sertraline | Sertraline The risk or severity of hypoglycemia can be increased when Acarbose is combined with Sertraline. |
Propafenone | Propafenone The therapeutic efficacy of Acarbose can be increased when used in combination with Propafenone. |
Tamsulosin | Tamsulosin The therapeutic efficacy of Tamsulosin can be increased when used in combination with Acarbose. |
Quetiapine | Quetiapine The therapeutic efficacy of Acarbose can be decreased when used in combination with Quetiapine. |
Cefepime Injection | Cefepime Injection Cefepime may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Cefprozil | Cefprozil Cefprozil may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Cefpodoxime | Cefpodoxime Cefpodoxime may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Cetirizine | Cetirizine Acarbose may decrease the excretion rate of Cetirizine which could result in a higher serum level. |
Paroxetine | Paroxetine The risk or severity of hypoglycemia can be increased when Paroxetine is combined with Acarbose. |
Tolcapone | Tolcapone Acarbose may decrease the excretion rate of Tolcapone which could result in a higher serum level. |
Citalopram | Citalopram The risk or severity of hypoglycemia can be increased when Citalopram is combined with Acarbose. |
Capecitabine | Capecitabine Acarbose may decrease the excretion rate of Capecitabine which could result in a higher serum level. |
Abacavir | Abacavir Acarbose may decrease the excretion rate of Abacavir which could result in a higher serum level. |
Pioglitazone | Pioglitazone The risk or severity of hypoglycemia can be increased when Acarbose is combined with Pioglitazone. |
Celecoxib | Celecoxib The therapeutic efficacy of Acarbose can be increased when used in combination with Celecoxib. |
Rosiglitazone | Rosiglitazone The risk or severity of hypoglycemia can be increased when Acarbose is combined with Rosiglitazone. |
Tolterodine | Tolterodine Acarbose may decrease the excretion rate of Tolterodine which could result in a higher serum level. |
Oseltamivir | Oseltamivir Oseltamivir may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Balsalazide | Balsalazide Balsalazide may increase the hypoglycemic activities of Acarbose. |
Nateglinide | Nateglinide The risk or severity of hypoglycemia can be increased when Acarbose is combined with Nateglinide. |
Rabeprazole | Rabeprazole Acarbose may decrease the excretion rate of Rabeprazole which could result in a higher serum level. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists